Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, Allergan, appointed, BBC, broader, Catalent, centralization, centralized, coupled, dictate, distributor, DSO, filer, inactive, Intrarosa, lieu, malignancy, mater, meaningful, mentioned, MYLAN, nonpublic, ogoing, outlined, outreach, ovariectomized, ovary, PA, prasterone, prioritize, proceed, pursuit, rat, reauthorize, reauthorized, remediate, satisfactory, shorter, soft, step, substitutable, supposed, topline, Trump, unchanged, unclear, viability, virtually, VMS, West, withholding, Woodstock
Removed:
affecting, AIB, annum, attributed, augment, broadband, calendar, centric, constant, differentiated, drawn, earn, electronic, encrypted, Gallup, home, ISO, loan, locally, negotiate, onsite, phone, pre, reclassified, repaid, requested, retirement, shopping, surpassed, travel, unemployment, unpaid, widespread
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification Pursuant to U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
TXMD similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Nos. 333-185156, 333-207837, 333-201171) on Form S-3 and (No. 333-191730) on Form S-8 of TherapeuticsMD, Inc. of our report dated March 12, 2015, with respect to the consolidated statements of operations, stockholders’ equity, and cash flows of TherapeuticsMD, Inc., for the year ended December 31, 2014 included in this annual report (Form 10-K).
/s/ Rosenberg Rich Baker Berman & Company
Somerset, NJ
February 28, 2017